Uveal MelanomaPhase 1NCT05607095
Lifileucel (LN-144/LN-145)
LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma
6 Phase 1 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Melanoma and skin6 studies
Uveal MelanomaPhase 1NCT05607095
LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma
Stage IV Melanoma With Brain MetastasesPhase 1/2NCT05588453
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
Metastatic Melanoma After Immune-Related ToxicityPhase 1NCT07237594
IL-17 Blockade to Decrease irAEs (REPLAY)
Neurofibromatosis Type 1 With Cutaneous NeurofibromasPhase 1/2NCT06159166
Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)
Cutaneous Squamous Cell CarcinomaPhase 1/2NCT05377905Papers
Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)
BRAF V600 Metastatic or Unresectable MelanomaPhase 1NCT04903119
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma